Dalton Greiner Hartman Maher & Co. lowered its stake in Metlife Inc (NYSE:MET) by 10.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 386,273 shares of the financial services provider’s stock after selling 44,197 shares during the quarter. Dalton Greiner Hartman Maher & Co.’s holdings in Metlife were worth $19,530,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Prudential Financial Inc. boosted its stake in Metlife by 71.4% in the 2nd quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock worth $201,778,000 after purchasing an additional 1,529,570 shares during the period. PGGM Investments boosted its stake in Metlife by 2.3% in the 3rd quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock worth $29,972,000 after purchasing an additional 12,978 shares during the period. Rockefeller Financial Services Inc. boosted its stake in Metlife by 189.7% in the 3rd quarter. Rockefeller Financial Services Inc. now owns 37,153 shares of the financial services provider’s stock worth $1,930,000 after purchasing an additional 24,330 shares during the period. Dai Ichi Life Insurance Company Ltd boosted its stake in Metlife by 49.1% in the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 140,168 shares of the financial services provider’s stock worth $7,701,000 after purchasing an additional 46,175 shares during the period. Finally, Intl Fcstone Inc. bought a new position in Metlife in the 2nd quarter worth about $383,000. Institutional investors and hedge funds own 76.24% of the company’s stock.
Several research analysts have commented on MET shares. Zacks Investment Research upgraded Metlife from a “hold” rating to a “buy” rating and set a $60.00 target price for the company in a research note on Thursday, November 9th. ValuEngine downgraded Metlife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 9th. Sandler O’Neill downgraded Metlife from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. Morgan Stanley lifted their price target on Metlife from $54.00 to $55.00 and gave the company an “equal weight” rating in a research report on Thursday, October 5th. Finally, Wells Fargo & Co set a $62.00 price target on Metlife and gave the company a “buy” rating in a research report on Thursday, December 14th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $57.90.
Shares of Metlife Inc (NYSE:MET) traded up $0.38 on Wednesday, hitting $52.36. The stock had a trading volume of 4,536,200 shares, compared to its average volume of 4,348,934. The company has a market cap of $55,880.00, a P/E ratio of 113.83, a PEG ratio of 1.20 and a beta of 1.49. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. Metlife Inc has a 12-month low of $44.26 and a 12-month high of $55.91.
Metlife (NYSE:MET) last announced its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.19. The company had revenue of $16.10 billion for the quarter, compared to analysts’ expectations of $15.47 billion. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. Metlife’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the firm posted $1.28 EPS. equities research analysts expect that Metlife Inc will post 4.4 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Monday, February 5th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.06%. Metlife’s dividend payout ratio is 347.83%.
In related news, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now directly owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Dalton Greiner Hartman Maher & Co. Has $19.53 Million Holdings in Metlife Inc (MET)” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://transcriptdaily.com/2018/01/10/dalton-greiner-hartman-maher-co-has-19-53-million-holdings-in-metlife-inc-met.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.